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To identify cellular functions involved in the early phase of the retroviral life cycle,
somatic cell mutants were isolated after selection for resistance to infection. Rat2 fibro-
blasts were treated with chemical mutagens, and individual virus-resistant clones were
recovered after selection for resistance to infection. Two clones were characterized in
detail. Both mutant lines were resistant to infection by both ecotropic and amphotropic
murine viruses, as well as by human immunodeficiency virus type 1 pseudotypes. One
clone showed a strong block to reverse transcription of the retroviral RNA, including
formation of the earliest DNA products. The second clone showed normal levels of viral
DNA synthesis but did not allow formation of the circular DNAs normally found in the
nucleus. Cell fractionation showed that the viral preintegration complex was present in
a form that could not be extracted under conditions that readily extracted the complex
from wild-type cells. The results suggest that the DNA was trapped in a nonproductive
state and excluded from the nucleus of the infected cell. The properties of these two
mutant lines suggest that host gene products play important roles both before and after
reverse transcription.
INTRODUCTION
The early phase of the retroviral life cycle consists of
virus entry, reverse transcription of the viral RNA into
DNA, movement into the nucleus, and insertion of the
DNA into the host genome to form the integrated
provirus (for a comprehensive review, see Coffin et al.,
1997). Although there has been considerable progress
in the identification of viral receptors and coreceptors
on the cell surface, the steps occurring after entry of
the virus particle into the cytoplasm are still poorly
understood. It remains particularly unclear what role
cellular functions may play in this process. There are
indications that cytoskeletal components are used by
retroviruses in the early stages of entry in some cell
types; for example, infection of NIH/3T3 cells by the
murine leukemia viruses (MuLVs) is blocked by no-
codazole, which disrupts microtubules, and by cy-
tochalasin D, which depolymerizes the actin network
(Kizhatil and Albritton, 1997). Furthermore, for most
retroviruses, cell division is required to permit effi-
cient infection. Although viral DNA can be synthe-
sized in nondividing cells, nuclear entry and viral
gene expression are blocked (Roe et al., 1993). This
observation suggests that the breakdown of the nu-
clear membrane associated with cell division, and per-
haps other processes, may be required to allow access
to the nucleus. Some retroviruses, notably human im-
munodeficiency virus type 1 (HIV-1) and other lenti-
viruses, are unusual in being able to infect nondivid-
ing cells, albeit at reduced efficiency as compared with
dividing cells (Weinberg et al., 1991; Lewis et al., 1992;
Lewis and Emerman, 1994). Infection by these viruses
may make use of nucleoporin-mediated transport into
the nucleus (Bukrinsky et al., 1992).
Biochemical approaches to the study of the early
phase of the life cycle are hampered by the fact that
most of the virion particles that enter an infected cell
are defective or at least nonproductive; the ratio of
physical particles to infectious units is typically at* Corresponding author.
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least 1000:1. Thus, the vast majority of the particles in
a recently infected cell may not be on a pathway to
successful infection, and biochemical analysis of their
properties may be misleading. Genetic approaches
could provide more definitive identification of host
functions needed for infection. However, only a few
mutants of mammalian cells affected in early steps of
infection by any virus have been identified. Some
mutant cell lines initially selected for drug resistance
were subsequently found to be defective in virus rep-
lication; for example, mutant cells selected for defects
in endocytosis and intracellular transport exhibited
increased resistance to Sindbis and vesicular stomati-
tis viruses (VSVs) (Robbins et al., 1984). Only rarely
have mutant cell lines been isolated by direct selection
for resistance to virus infection (Morgan et al., 1973;
Taber et al., 1976).
The recovery of mutant lines resistant to virus infec-
tion at useful efficiencies requires strong selections.
Most somatic cell mutants have been isolated with
selections for resistance to cytotoxic compounds (e.g.,
Gupta and Siminovitch, 1976; Funanage, 1982; Ripka
and Stanley, 1986; Goldmacher et al., 1987; Chopra et
al., 1990; Stanley et al., 1990; Meuth and Harwood,
1991), and the affected gene products are restricted to
a limited number of particular metabolic pathways by
the availability of such compounds. More recently,
however, new selectable DNA constructs have been
used to permit recovery of mutant lines affected in a
wider range of functions, including the responses to
interferon a and g (Pellegrini et al., 1989; John et al.,
1991; McKendry et al., 1991; Mao et al., 1993). These
lines were crucial to the subsequent identification of
the Jak and STAT gene products in signal transduction
(Velazquez et al., 1992; Darnell et al., 1994). Mutant
lines defective in the responses to transforming
growth factor b have been isolated in similar ways
(Laiho et al., 1990, 1991; Hocevar and Howe, 1996).
To identify cellular functions that might be impor-
tant for retrovirus infection, we have devised a selec-
tion for the isolation of virus-resistant cell mutants. A
permissive parental line was subjected to heavy mu-
tagenesis by chemical mutagens and then challenged
by exposure to retroviral preparations carrying a se-
lectable marker. Rare virus-resistant clones that could
not be transduced by the genetically marked retrovi-
ruses were then isolated. Two such resistant lines were
examined in detail. One such line blocked challenge
by retrovirus infection before reverse transcription of
the viral RNA into DNA. The second line allowed
normal viral DNA synthesis but retained the DNA in
an abnormal state in the cytoplasm and did not allow
its nuclear entry. These lines suggest that host func-
tions play important roles in the early steps of retro-
viral infection, and that these functions might provide
new sites for antiviral intervention.
MATERIALS AND METHODS
Tissue Culture
Rat2 cells, 293T cells, and derivative cell lines were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% FBS (HyClone, Logan, UT). NIH/3T3 cells and derivative cell
lines were maintained in DMEM supplemented with 10% calf se-
rum (HyClone).
Producer Cell Lines and Viruses
To generate ecotropic and amphotropic MuLV-thymidine kinase
(TK) viruses, pMA348 (a generous gift from Drs. Manual Caruso
and Arthur Bank, Columbia University), a Moloney MuLV–derived
retroviral vector expressing the herpes TK gene was stably intro-
duced into GP1E86 and GP1EnvAm12 packaging cells (Markowitz
et al., 1988a,b), respectively, by cotransformation with pSV2-neo
DNA. Transfected cells were selected in medium containing 800
mg/ml G418. Approximately 100 G418-resistant clones from each
transfection were picked individually and expanded. Supernatants
from each individual clone were diluted 100-fold and used to infect
naive Rat2 cells for 2 h to evaluate the titer of each producer clone.
Ten days after selection in HAT (hypoxanthine, aminopterin, thy-
midine) medium, the Rat2 cells were stained with Giemsa, and the
number of colonies was counted. One producer clone from each
transfection that released the highest titer of transducing virus was
chosen and expanded. The supernatants from these two clones were
used as the TK virus preparations in the subsequent experiments.
Ecotropic and amphotropic MuLV-N2 viruses have been reported
previously (Eglitis et al., 1985; Markowitz et al., 1988a,b). The pMA-
Luc vector was generated by replacing the TK gene of pMA348 with
the luciferase coding region recovered from p19 Luc (van Zonn-
eveld et al., 1988) by PCR. Ecotropic MuLV-Luc virus was generated
by stable transformation of the GP1E86 packaging line with pMA-
Luc DNA together with pSV2-neo DNA. G418-resistant clones were
individually tested for virus production, and the one that produced
the highest titer of virus was chosen for virus production. Ecotropic
MuLV-green fluorescent protein (GFP) virus was generated by sta-
bly transfecting plasmid MFG-GFP DNA (Verhasselt et al., 1998)
into ecotropic phoenix producer cells (Kinsella and Nolan, 1996).
Two weeks after transfection, the cells were sorted by FACS to
obtain a GFP-positive population that was used as the source of
MuLV-GFP virus. The virus was then used to infect GP1EnvAm12
amphotropic packaging cells to generate amphotropic MuLV-GFP
producers. The method for producing VSV-G–enveloped HIV-GFP
viruses has been previously reported (Naldini et al., 1996). Ecotropic
and amphotropic HIV-GFP viruses were produced using a similar
protocol but replacing pMD.G, a plasmid expressing VSV-G, with
either pSV-E-MLV-env or pSV-A-MLV-env, plasmids expressing
ecotropic or amphotropic envelopes, respectively (Landau and Litt-
man, 1992). The HIV-GFP virus with the VSV-G envelope for use in
analysis of viral DNA synthesis in vivo was further purified to
remove residual plasmid DNA present from the transfection. The
virus preparation was first treated with 25 U/ml DNase I at 37°C for
1 h and then concentrated by centrifugation through a 25% sucrose
step gradient onto a 45% sucrose cushion. The virus at the interface
of the gradient was collected, diluted, and used directly for infec-
tions. To control for contaminating DNA, the undiluted virus was
heat-inactivated by treatment at 80°C for 15 min and used for
infection as before.
Infection of Cultured Cells and Assays for
Transduction
All infections were performed in the presence of 8 mg/ml poly-
brene. Unless otherwise specified, infections were carried out for
only 2 h. For amphotropic MuLV-GFP the infections were done for
5 h to increase the infection efficiency. Cells expressing puromycin
resistance were selected by growth in medium containing puromy-
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cin (5 mg/ml); those expressing neomycin resistance were selected
with G418 (400 mg/ml). The level of luciferase expression was
monitored by preparing lysates and assaying enzyme activity using
luciferase assay reagents (Promega, Madison, WI) according to the
manufacturer’s instructions. Samples were read on a Lumat lumi-
nometer (Wallac, Gaithersburg, MD) to obtain light units; values
were corrected to units per 20 mg of total protein. Concentrations of
protein were determined using the Bio-Rad (Hercules, CA) dye
reagent. Cells infected with GFP viruses were analyzed by flow
cytometry to determine the number of transduced cells and the
levels of GFP expression.
Random Mutagenesis and Trifluorothymidine (TFT)
Selection
Rat 2 cells were first plated at very low density so that single clones
could be picked. Two clones were expanded and tested for their
susceptibility to both ecotropic and amphotropic MuLV-TK virus
infection. Both clones were comparable with the parental cells in
terms of susceptibility, cell growth rate, and morphology. One
clone, Rat2-2, was used in this report.
Ethyl-Methane Sulfonate (EMS) Treatment. 106 Rat2-2 cells seeded
on one 10-cm plate were incubated with medium containing 700
mg/ml EMS (Sigma, St. Louis, MO) at 37°C for 16 h. The treated cells
were allowed to recover for 2 weeks before infection and selection.
ICR-191 Treatment. 106 Rat2-2 cells seeded on one 10-cm plate were
incubated with medium containing 1.5 mg/ml ICR-191 (Sigma) at
37°C for 1.5 h so that 50% of the cells were killed, a dose of mutagen
that results in maximum mutagenesis efficiency. The cells were
allowed to recover for 4 d before being trypsinized and replated.
The cells were then treated with ICR-191 three more times as de-
scribed above. One week after the last treatment the cells were
replated and subject to infection and selection. The mutagenized
cells were repeatedly infected with ecotropic and amphotropic
MuLV-TK viruses and then selected in DMEM supplemented with
10% dialyzed FBS (Life Technologies, Gaithersburg, MD) and 13 mM
TFT (Sigma).
Cell Cycle Analysis
Cells (106) of each line were seeded in 10-cm dishes 2 d before the
experiment. At 30–80% confluency, the cells were analyzed for their
cell cycle profile with a cellular DNA flow cytometric analysis kit
(Boehringer Mannheim, Indianapolis, IN) following the manufac-
turer’s instructions.
PCR Primers and Reaction Conditions
Primers to amplify GFP sequence were: forward primer, GFP-FP
(59-CTGTCAGTGGAGAGGGTGAAGGTGATGCAA-39); and re-
verse primer, GFP-RP (59-CCCAGCAGCTGTTACAAACTCAA-
GAAGGACCAT-39). Primers to amplify MuLV minus strand strong
stop DNA were: forward primer, MSS-FP (59-GCGCCAGTCCTC-
CGATTGACTG-39); and reverse primer, MSS-RP (59-CGGGTAGT-
CAATCACTCAG-39). Primers to specifically amplify MuLV plus
strand sequence (from U5 to R) were: forward primer, PS-FP (59-
GTGATTGACTACCCGTCAGC-39); and reverse primer, PS-RP (59-
GACCTTGATCTTAACCTGGG-39). Primers to amplify the MuLV
long terminal repeat (LTR)–LTR junction, MR5784 and MR4091,
have been previously reported (Smith et al., 1997). Primers to am-
plify the HIV minus strand strong stop DNA and the elongated plus
strand DNA have also been reported (Braaten et al., 1996).
PCR conditions for amplifying GFP sequence were 94°C for 30 s,
60°C for 30 s, and 72°C for 90 s. The PCR was performed with native
Taq polymerase (Perkin Elmer, Emeryville, CA) for 25 cycles to
amplify Hirt DNA, 30 cycles to amplify cell extracts and 40 cycles to
amplify fractionated cytoplasmic extract. PCR conditions for ampli-
fying MuLV minus strand strong stop DNA were 94°C for 30 s, 55°C
for 30 s, and 72°C for 60 s for 30 cycles. The same conditions were
used for 25 cycles for amplifying plus strand DNA and for 30 cycles
for amplifying the LTR–LTR junction. PCR conditions for amplify-
ing HIV minus strand strong stop DNA and plus strand DNA were
94°C for 30 s, 58°C for 30 s, and 72°C for 60 s for 25 cycles.
Fractionation of Infected Cells
Cells (4 3 107) were incubated with undiluted ecotropic MuLV-GFP
virus at 4°C for 2 h and then transferred to 37°C to initiate infection.
At various times after the shift, the cells were trypsinized and lysed.
Two lysis methods were used. In one procedure, the cells were
resuspended in a hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF, and 10 mg/ml
leupeptin) using 10 strokes in a Dounce homogenizer until the cell
membrane was broken but nuclei remained intact, as monitored by
microscopic inspection. The lysate was then centrifuged at 3300 3 g
for 15 min. The supernatant was transferred to a new tube and
centrifuged again at 8000 3 g for 20 min. This supernatant was
referred to as cytoplasmic extract. The pellets from both centrifuga-
tion were pooled, and DNA was extracted for virus determination
(Hirt, 1967). The other extraction method was as previously de-
scribed (Brown et al., 1987; Bowerman et al., 1989). Briefly, 8 h after
infection the cells were lysed in 0.025% digitonin in buffer A (10 mM
Tris-HCl, pH 7.4, 225 mM KCl, 5 mM MgCl2, 1 mM DTT, and 20
mg/ml aprotinin). The lysate was centrifuged at 1000 3 g for 3 min.
The supernatant from this separation was recentrifuged at 8000 3 g
for 20 min; this supernatant is referred to as cytoplasmic extract. The
pellet of the first centrifugation was resuspended in buffer A and
homogenized with a ball-bearing homogenizer to break the nuclear
membrane, and the preparation was centrifuged at 10,000 3 g for 20
min. The supernatant from this separation was referred to as nu-
clear extract, and the pellet was referred to as secondary pellet.
To monitor the isopycnic density of the cytoplasmic extracts,
samples were loaded on a linear gradient prepared with 20% su-
crose in buffer (50 mM potassium phosphate, pH 7.4, 10 mM DTT,
and 10 mg/ml aprotinin) and 70% sucrose in D2O and centrifuged at
35,000 rpm (SW55 rotor; Beckman Instruments, Palo Alto, CA) for
20 h. The gradient was divided into 10 fractions with 500 ml in each
fraction.
RESULTS
Selection for Virus-resistant Mutant Cell Lines
A strategy was devised for the isolation of somatic cell
mutants resistant to infection by retroviruses (Figure
1). Cells susceptible to virus and deficient in TK were
mutagenized and then infected with a retroviral vec-
tor carrying the herpes virus TK gene. The parental
cells would be infected and become TK positive,
whereas any rare mutant virus-resistant cells would
remain TK negative. The mutant cells could then be
recovered by growth in TFT, which would kill the
infected TK-positive cells but spares the uninfected
TK-negative mutants.
The Rat2 cell line was chosen as parent for the
mutagenesis for several reasons: the line is highly
susceptible to the MuLVs and expresses both the eco-
tropic and amphotropic virus receptors; it is relatively
stable genetically and has a nearly diploid karyotype
(N 5 44); and it is deficient for TK, a powerful select-
able and counterselectable marker. The cells were mu-
tagenized by exposure to high doses of a chemical
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mutagen and allowed to recover and express the phe-
notype for several days. The cultures were then chal-
lenged with a mixture of two virus preparations, con-
taining either the ecotropic or the amphotropic
envelope protein, and delivering the herpes virus TK
gene via the same retroviral vector. The use of a mix-
ture of viruses was designed to infect those uninter-
esting mutant cells that lacked either one of the two
receptors. Repeated infection was found helpful to
ensure delivery of the TK gene to the bulk of the cells.
Finally, the rare TK-negative cells were selected by
plating in medium containing TFT. The background of
surviving cells in the selection protocol was as low as
1 in 105 cells plated in this medium.
Isolation of Virus-resistant Clones
Initial efforts to isolate virus-resistant mutants used
the mutagen EMS, which mainly induces substitu-
tions, both transversions and transitions. After infec-
tion with the TK virus preparations, ;107 cells were
plated in TFT medium and gave rise to ;50 surviving
colonies. These clones were individually expanded
into large cultures and retested for virus resistance by
challenge with a viral vector preparation transducing
the neomycin resistance marker N2 in an ecotropic
virus coat (Eglitis et al., 1985). A small number of the
clones exhibited significant resistance, showing 10- to
300-fold reductions in the efficiency of transduction to
G418 resistance (Table 1). Control experiments with-
out mutagen did not produce any such resistant col-
onies, suggesting that the EMS did increase the muta-
tion frequency. The phenotype of these clones,
however, was not stable. As the cells were cultured
over the subsequent months, the resistance gradually
disappeared. Similar observations have been made
with other mutants isolated by EMS mutagenesis (Na-
kamura and Okada, 1983).
Similar experiments were performed using the
chemical mutagen ICR-191, an acridine half-mustard
that induces frameshift mutations and chromosomal
rearrangements (MacInnes et al., 1982) and was used
to isolate stable mutants affected in the Jak-STAT path-
ways (Pellegrini et al., 1989; John et al., 1991; McKen-
dry et al., 1991; Mao et al., 1993). Approximately 2 3
107 cells, divided into 20 separate pools, were sub-
jected to multiple rounds of exposure to ICR-191. The
dosage of mutagen was controlled to induce killing of
;50% of the cells at each round. After a total of four
rounds of mutagenesis the cells were allowed to re-
cover for 2 weeks, and then 2 3 106 cells in each pool
were repeatedly infected with the ecotropic and am-
photropic viral vectors over the course of 2 d. Finally,
the cells were grown in medium containing 13 mM
TFT to kill the infected TK-positive cells and select for
Figure 1. Schematic representa-
tion of the strategy for isolating
mutant cells resistant to retrovi-
ral infection. TK2, thymidine ki-
nase deficient; TK1, thymidine
kinase proficient.
Table 1. Selection of virus-resistant cell clones
Mutagen








No mutagen 2 3 107 63 0
EMS
Exp. 1 1 3 107 72 8 0
Exp. 2 8 3 106 29 3 0
ICR-191 2 3 107 75 9 2
a Total number of colonies surviving TFT selection.
b The surviving clones were individually tested for resistance to neoR viral vector. Those demonstrating .10-fold reduction in virus
sensitivity were considered resistant clones.
c The resistant clones were cultured for .8 weeks and retested for resistance to neoR viral vector. Those retaining resistance were considered
stable clones.
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any virus-resistant mutants. More of the viral vectors
were added during the selection to target any suscep-
tible cells and lower the background of survivors.
Approximately 100 clones were isolated and retested
for resistance to infection by ecotropic N2 virus. A
total of nine clones exhibited .10-fold resistance to
infection; two of these, clones R3-2 and R4-7, showed
the highest level of resistance and stability and were
chosen for further characterization.
Growth Properties of Mutant and Control Clones
After mutagenesis, the unselected cell cultures were
observed to grow somewhat more slowly than the
parental population. Virus replication is known to
depend on cell division, and thus a simple reduction
in the growth rate or an alteration in the cell cycle
behavior could cause virus resistance. To examine this
possibility, the doubling times of clones R3-2 and R4-7
were determined and compared with two clones ran-
domly picked from the mutagenized cultures without
infection or TFT selection. These clones, RC-1 and
RC-2, were fully sensitive to virus infection (see be-
low). All the clones, both the virus-resistant and the
virus-sensitive lines, showed modest reductions in
their growth rate compared with the parental popula-
tion (Table 2). Thus, the reduction in growth rate by
itself did not cause virus resistance, suggesting that
R3-2 and R4-7 exhibited an additional or unrelated
mechanism of resistance.
To characterize the growth behavior of the clones
further, the cells were stained with propidium iodide
and examined for DNA content by flow cytometry.
The distribution of cells in each stage of the cell cycle
was determined (Table 2). For R3-2 cells, the distribu-
tion in each phase was very similar to controls,
whereas for R4-7 cells, more cells were found in the S
and G2/M phases than controls. The altered pattern
did not correlate with the doubling times of the clones
or with the virus resistance of the mutants. Thus, there
was no simple alteration in the growth of these clones
that could on its own account for their resistance.
Measurement of the Level of Resistance to
Virus Infection
To determine the magnitude of the resistance to virus
infection in a single round, cultures were challenged
with preparations of a viral vector expressing the neoR
gene (the N2 vector; Eglitis et al., 1985) in either eco-
tropic or amphotropic envelopes. The infected cells
were plated in medium containing G418, and the
number of transduced colonies was counted after
10–14 d. Both R3-2 and R4-7 were highly resistant to
both ecotropic and amphotropic virus infection (Table
3). Mutant R3-2 was ;1000-fold resistant, and mutant
R4-7 was ;100-fold resistant, compared with the RC-1
and RC-2 controls. Similar results were obtained with
a puromycin-transducing virus (our unpublished re-
sults).
Bypass of the Virus Resistance by DNA
Transformation
The resistance to virus manifest by clones R3-2 and
R4-7 could in principle be due to blocks early in in-
fection, before establishment of the integrated provi-
rus, or later in infection, during expression of the
provirus. To distinguish between these possibilities,
the ability of the cells to express viral constructs was
assessed after calcium phosphate–mediated transfor-
mation by cloned proviral DNAs. Clones R3-2 and
R4-7 were readily transformed by the proviral DNA of
the N2 vector, yielding slightly more drug-resistant
colonies than the controls (Table 4). The variation
exhibited by the clones was within the range usually
attributable to variation in transfection efficiency. Sim-
ilarly, the clones were able to express puromycin re-
sistance at normal levels from the proviral DNA con-
struct (Table 4). Thus, there was no apparent defect in
transcription from the provirus or other steps in-
volved in expression of the transduced markers. The
block to virus-mediated transduction in both mutant
Table 2. Growth properties of virus-resistant cells




RC-2 21.5 63 23 14
R3-2 29.5 66 19 15
R4-7 20.0 43 30 27
a Td, doubling time.
b Asynchronously dividing cells were stained with propidium io-
dide and analyzed by flow cytometry.
Table 3. Resistance of mutant cell lines to neoR viral vectors
Cell line
Exp. 1a Exp. 2a
Eco-N2 Amp-N2
Eco-N2 Amp-N2
Undiluted 1:10 Undiluted 1:10
RC-1 82 46
RC-2 119 70 TMTCb .2000 TMTCb 884
R3-2 0 1 58 3 2 0
R4-7 1 0 122 26 93 7
a Number of drug-resistant colonies after infection with the indi-
cated viral preparation.
b TMTC, too many to count.
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lines was thus probably manifest during the early
phase of infection.
Similar experiments were also performed with a
virus vector expressing the luciferase gene. The cells
were infected and grown for 2 d, and lysates were
prepared and assayed for luciferase activity as a mea-
sure of infection efficiency. In these experiments the
R3-2 and R4-7 clones both exhibited only a 20-fold
reduction in luciferase expression compared with con-
trols (Table 5). Thus, in this short-term assay the mu-
tant clones exhibited substantial resistance to infec-
tion, although less than in the long-term assay for
drug-resistant colony formation that required stable
expression of the provirus. Introducing the same con-
struct by DNA-mediated transformation, as with the
selectable viruses, showed no block to expression of
the reporter gene (Table 5).
Resistance to HIV Pseudotypes using Any of Three
Envelope Proteins
To explore the breadth of the resistance, the mutant
clones were challenged by infection with HIV-based
retroviral vectors using various envelope proteins. An
HIV vector expressing the GFP was used to transfect
293T cells along with one helper plasmid expressing
HIV Gag and Pol genes, and another expressing either
the MuLV ecotropic envelope, the MuLV amphotropic
envelope, or the VSV-G envelope protein. MuLV vec-
tors expressing GFP in MuLV particles were used for
direct comparison. These various virus preparations
were used to infect clones R3-2 and R4-7, and the
number of infected cells was determined by flow cy-
tometry. As expected, both clones were highly resis-
tant to the MuLV vectors, yielding ;30-fold fewer
infected cells than the control line (Figure 2). The R3-2
clone was somewhat more resistant to the MuLV vi-
ruses than R4-7. Both clones were also highly resistant
to the HIV vectors, using any of the three envelopes
(Figure 2). Thus, the clones showed resistance to two
very different retroviruses. Curiously, with the HIV-1
vectors, the R4-7 clone was consistently more resistant
than the R3-2, just the reverse of the behavior with
MuLV vectors. This result indicates that the magni-
tude of the resistance showed a dependence on the
origin of either the transducing viral genome or the
viral core proteins. The fact that the cells were resis-
tant to viruses using any of three receptors again
suggests that the block is not likely to be at the level of
the receptor.
Analysis of Proviral DNA Synthesis in
Mutant Cells
To identify the position of the blocks to infection, the
course of viral DNA synthesis was examined after
acute infection of mutant and control cells. Cells were
infected with ecotropic MuLV-GFP vector at various
dilutions. At different times after infection, cells were
lysed, low-molecular-weight DNA was extracted, and
the viral DNA was analyzed by PCR followed by gel
electrophoresis. In the RC-2 control cells, viral DNA
was easily detected using primers specific for the GFP
sequences, and the levels of the amplified DNA prod-
uct correlated well with the levels of input virus,
demonstrating that the assay was not saturated but
Table 4. Functional expression of drug resistance after DNA-medi-
ated transformation of mutant cell lines
Cell line
N2a pBabe-purob
Exp. 1 Exp. 2
10 mg 1 mg 1 mg 10 mg 1 mg
RC-2 170 31 5 187 17
R3-2 89 38 50 NAc 45
R4-7 250 91 15 500 79
a Number of colonies growing in G418-containing medium after
transformation by the indicated amount of DNA.
b Number of colonies growing in puromycin-containing medium
after transformation by the indicated amount of DNA.
c NA, not available.
Table 5. Expression of luciferase activity after infection or transduction with MuLV-Luc viral vector
Cell line
Virus infectiona DNA transfectionb
Prep 1 Prep 2 Prep 3 20 ng 200 ng 2 mg
RC-2 11,043 12,698 5,188 1,609 11,586 111,296
R3-2 400 522 191 7,410 57,421 498,101
R4-7 428 323 146 4,135 19,626 178,160
a Cells were infected with different preparations of ecotropic MuLV-Luc virus, and lysates were assayed for luciferase activity. The values
are normalized to input protein.
b Cells were transfected with the indicated amounts of MuLV-Luc DNA, and lysates were assayed for luciferase activity. The values are
normalized to input protein.
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responded to input DNA (Figure 3A). Comparable
levels of viral DNA were detected in R3-2 cells, sug-
gesting that this mutant clone had no defect in syn-
thesis, at least of the minus strand of the genome. To
examine later steps in reverse transcription, PCR
primers that specifically amplify plus strand DNA
products were used (Figure 3B). Plus strand DNA was
formed at normal levels in the R3-2 cells, indicating
that most of the course of reverse transcription oc-
curred normally and that later steps in infection must
be affected.
In contrast to the results with R3-2, only very low
levels of MuLV viral DNA were detected in R4-7 cells
using the GFP primers, suggesting a block before for-
mation of long minus strand DNAs (Figure 3A). The
amount of DNA was reduced ;30-fold from that seen
in the control line, consistent with the reduction in
GFP-positive cells after infection. To examine earlier
steps in reverse transcription, primers were used that
detect minus strand strong stop DNA, the first detect-
able product of DNA synthesis. The levels of this
DNA after infection with ecotropic MuLV-N2 or
MuLV-GFP vectors were also dramatically reduced,
;30- to 100-fold, compared with the control cells (Fig-
ure 3C). Thus, the block to infection in R4-7 cells was
at or before the earliest step of reverse transcription.
This result places the defect close to virus entry into
the cell. To repeat the test with a different receptor,
R4-7 and control cells were infected with amphotropic
MuLV-GFP, and the viral DNA was again examined
using PCR primers specific for GFP. The viral DNA
was dramatically reduced in the mutant (Figure 3D),
to a similar extent as with the ecotropic virus. To
further rule out potential defects in the receptor, R4-7
cells were transformed with a DNA construct overex-
pressing the ecotropic receptor and then challenged
with ecotropic vectors; there was no change in the
resistance (our unpublished results). These findings
strongly suggest that resistance in the R4-7 cells is not
at the level of the receptor but is soon after entry and
before reverse transcription.
The early steps in infection by HIV-1 are broadly
similar to those for MuLV, but the nature of the pre-
integration complex may differ, and there are signifi-
cant differences in that HIV-1 can infect nondividing
cells. To test whether HIV-1 infection was blocked at
similar stages as MuLV infection, VSV-G–
pseudotyped HIV-GFP virus was used to infect the
mutant cells, and the course of viral DNA synthesis
was analyzed by PCR (Figure 3E). As seen with
MuLV-GFP infection, formation of the HIV-1 DNA
was dramatically inhibited in the R4-7 clone, suggest-
ing a similar block soon after entry and before reverse
transcription. Both minus strand strong stop DNA and
elongated plus strand DNAs were blocked. As with
MuLV-GFP, synthesis of the HIV-1 DNA was normal
in the R3-2 cells. Both strong stop DNA and elongated
DNAs were formed normally, suggesting a block only
after completion of reverse transcription.
Formation of Circular Viral DNAs
After completion of reverse transcription, linear viral
DNA enters the nucleus and gives rise to circular
DNA forms containing one or two copies of the LTR.
These circular DNAs are not intermediates on the
normal pathway to formation of the integrated provi-
rus (Ellis and Bernstein, 1989; Lobel et al., 1989) but
nevertheless serve as hallmarks of the entry of the
DNA into the nucleus. To test for formation of circular
MuLV DNAs, the levels of the two-LTR circle in
acutely infected cells were estimated using PCR prim-
ers located in the U5 and U3 portions of the LTR. In
control RC-2 cells, circular DNA was first detected as
soon as 12 h after infection, and higher levels were
found at later times (Figure 3F). In mutant R3-2 cells,
virtually no circular DNA was detectable even 36 h
after infection, suggesting a major block after reverse
transcription and before nuclear entry.
Figure 2. Resistance of mutant cells to GFP virus infection. RC-2
cells (open triangles), R3-2 cells (closed circles), and R4-7 cells (open
circles) were infected with the indicated viruses at indicated dilu-
tion. The number of infected cells, as indicated by expression of
GFP, was determined by flow cytometry.
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Although R4-7 cells synthesized very little viral
DNA, similar tests were performed to test for circular
forms. The R4-7 cells did produce low, but detectable,
levels of this DNA (Figure 3F). The small amount of
circular DNA was consistent with the reduced amount
of initial products of reverse transcription. Thus, these
Figure 3. Analysis of viral DNA in infected mutant cells. RC-2 and mutant cells were infected with various dilutions of virus, and the
amount of viral DNA synthesized in the infected cells was measured by PCR under conditions controlled such that the yield of PCR product
was proportional to the input DNA. (A) Cells were infected with MuLV-GFP virus at various dilutions. At different time points the viral DNA
in the infected cells was extracted and detected by PCR using primers that specifically amplify the GFP sequence. (B) The same preparations
at the 24-h postinfection time point in A were used as templates to detect the synthesis of plus strand viral DNA in the infected cells. The
migration position of the PCR product is indicated. (C) Cells were infected with either ecotropic MuLV-GFP or ecotropic MuLV-N2 virus at
various dilutions, as indicated. Twenty four hours after infection the cells were collected, and minus strand strong stop DNA was detected
by PCR. The migration position of the PCR product is indicated. (D) RC-2 and R4-7 cells were infected with amphotropic MuLV-GFP virus
at various dilutions. Twenty-four hours after infection, viral DNA synthesis was analyzed by PCR using primers that amplify GFP sequences.
(E) Cells were infected with VSV-G–pseudotyped HIV-GFP virus at various dilutions, as indicated. At 24 h after infection, cells were collected,
and minus strand strong stop DNA and plus strand DNA were detected by PCR. The migration positions of the PCR products are indicated.
H.I. virus, heat-inactivated virus was used as a control for plasmid DNA contamination of the virus. (F) The same preparations from A were
analyzed by PCR using primers that specifically amplify the LTR–LTR junction to detect circular DNAs in the nucleus.
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cells apparently translocated into the nucleus a normal
proportion of the small amount of DNA that was
synthesized.
Characterization of the Viral DNA in R3-2 Cells
The failure of the R3-2 cells to form circular viral
DNAs suggested that nuclear import or intracellular
transport of the DNA might be affected. To determine
the state of the unintegrated viral DNA, cell extracts
were prepared in various conditions, fractionated, and
assayed for the presence of the DNA. Cells were ex-
posed to ecotropic MuLV-GFP virus for 2 h at 4°C and
then transferred to 37°C to allow infection to proceed
synchronously. At 4 or 8 h after infection, cells were
harvested and lysed with a mild hypotonic buffer, and
the lysates were fractionated by centrifugation into a
soluble fraction and an insoluble pellet (Figure 4A). In
the control RC-2 cells, approximately equal amounts
of viral DNA were recovered in the soluble and insol-
uble fractions (Figure 5A). In contrast, in the R3-2 cells,
although normal levels were recovered in the insolu-
ble fraction, almost no DNA was detected in the sol-
uble fraction. This result suggests that in R3-2 cells the
viral preintegration complex was trapped in a state
that could not be solubilized by hypotonic buffer.
Cell lysates were also prepared using harsher con-
ditions in buffer containing digitonin (Figure 4B).
These lysates were fractionated by low-speed centrif-
ugation into a soluble extract and a pellet containing
nuclei, membrane, cytoskeleton, and associated pro-
teins. Under these conditions, viral DNA was detected
in the soluble fraction of both the RC-2 and R3-2 cells,
and similar levels were also detected in the pellet
(Figure 5B). The pellet was resuspended in the same
buffer, extracted with a Dounce homogenizer, and
Figure 4. Schematic representation of the procedure for fraction-
ating infected cells. RC-2 and R3-2 cells were infected with undi-
luted ecotropic MuLV-GFP virus and extracted with either hypo-
tonic buffer (A) or buffer containing digitonin (B).
Figure 5. Analysis of viral DNA in the fractionated cell extracts by
PCR using primers that amplify GFP sequences. The migration
positions of the PCR product are indicated with arrows. (A) Four or
8 h after infection cells were collected and fractionated. The low-
molecular-weight DNA in the pellet (Hirt extract) was resuspended
in 20 ml of Tris-EDTA plus 10 mg/ml RNase A. Five of 300 ml of
cytoplasmic extract or 1 of 20 ml of the pellet DNA were PCR
amplified to detect viral DNA. (B) Eight hours after infection the
cells were collected by trypsinization. One-third of the cells were
used to extract total DNA by the Hirt procedure. The rest of the cells
were fractionated as described in Figure 4B. Five of 300 ml of each
extract or 1 of 60 ml of the total DNA were used to assay viral DNA
by PCR. (C) The cytoplasmic extracts from B were fractionated by
centrifugation on a 20–70% sucrose gradient. The gradient was
equally divided into 10 fractions of 500 ml each. Five microliters of
solution from each fraction were used to detect viral DNA by PCR.
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separated by centrifugation again into a soluble nu-
clear extract and a secondary pellet. Although viral
DNA was readily detected in the nuclear extract of the
control RC-2 cells, very little was recovered in this
fraction in the R3-2 cells (Figure 5B). This result is
consistent with a failure of the DNA to move into the
nucleus. No difference in the amounts of viral DNA in
the secondary insoluble pellet was detected between
the two cell lines.
To test for any profound differences in the preinte-
gration complex extracted in the harsher conditions,
the digitonin-soluble fractions from both cell lines
were analyzed by equilibrium density gradient cen-
trifugation (Figure 5C). The DNAs from both lines
localized at similar positions in the gradients, at a
density of ;1.32 g/ml, indicating no gross difference
in the complexes.
DISCUSSION
The procedure devised for the isolation of virus-resis-
tant mutants combined an efficient transduction of
cells by viruses carrying the TK gene with a powerful
selection using the cytotoxic thymidine analogue TFT.
The transducing virus preparations were applied re-
peatedly to the cells to maximize the number of pa-
rental cells that were infected. A mixture of two vi-
ruses targeted to different cell surface receptors,
ecotropic and amphotropic viruses, was used to pre-
vent the recovery of uninteresting mutants that lacked
one or the other of the two receptors. The TFT itself
was a highly efficient agent for the elimination of the
transduced cells. The combined selection resulted in
the survival of ;1 in 105 of the input cells, a low
enough background that the true virus-resistant cells
could be identified among the survivors by direct test
after cloning. The two mutagens used, EMS and ICR-
191, generated approximately equal numbers of virus-
resistant cells—a few such mutants out of ;100 sur-
viving clones—but with very different properties. The
phenotypes of the EMS-induced clones were quite
unstable, and during passage the cells reverted to
normal virus sensitivity. The ICR-191–induced clones,
however, were relatively stable, and even after pro-
longed passage the lines continued to show high level
resistance.
The two cell lines characterized in detail, R3-2 and
R4-7, showed very significant blocks to virus infection.
When tested with either ecotropic or amphotropic vi-
ruses expressing the neomycin resistance gene, the
cells showed ;1000- and 100-fold lower titers, respec-
tively, than control cells. Somewhat lower resistance
was observed with viruses transducing other markers,
the GFP or luciferase genes, as scored by flow cytom-
etry or enzyme assay. The basis for this difference is
unclear but may reflect the difference in duration and
level of expression required for the two types of mark-
ers. Transduction of the neoR marker requires long-
term expression sufficient to mediate cell growth over
a 2-week period, whereas GFP or luciferase transduc-
tion only requires short-term expression. In any event,
the level of resistance manifest by these lines suggests
that it may be possible to complement or suppress the
defect with DNAs and thus to select from a large
library of cDNA expression constructs for those clones
that restore normal susceptibility to infection. The
level of resistance, however, is probably not as strong
as would be required to allow the one-step selection of
one such clone from a complete library of perhaps 106
cDNAs, so repeated cycles of selection may be re-
quired.
Virus infection of both mutant clones examined here
was blocked during the early phase of the life cycle.
The blocks were observed no matter whether eco-
tropic or amphotropic envelope or even the VSV-G
protein was used for entry, suggesting a postentry
step that is independent of any particular receptor.
Remarkably, the cells were also resistant to infection
by HIV-1 vectors, suggesting an alteration in a very
general and basic aspect of retrovirus entry. The
courses of infection by MuLV and HIV-1 are different
in many regards: ecotropic MuLV entry is inhibited by
compounds that block endosomal acidification, sug-
gesting intracellular fusion of viral and host mem-
branes (Marsh and Helenius, 1989; Nussbaum et al.,
1993), whereas HIV-1 fusion occurs at the cell surface;
and MuLV infection requires cell division (Roe et al.,
1993), whereas HIV-1 does not (Lewis and Emerman,
1994). The fact that the mutant cells were resistant to
both viruses indicates that a common, shared aspect of
infection was blocked. It is also noteworthy that the
two clones showed different levels of resistance to
HIV-1 and MuLV; R3-2 was more resistant to MuLV,
whereas R4-7 was more resistant to HIV-1. Thus, there
was some virus specificity in the altered host func-
tions.
The R4-7 cell line prevented an early step of virus
infection, before reverse transcription could form the
preintegrative double-stranded DNA. Analysis of the
DNA suggested that even the earliest intermediate,
the minus strand strong stop DNA, was not synthe-
sized. This stage of the life cycle, sometimes termed
“uncoating,” is poorly understood, but many mutant
viruses are also blocked at this time. Mutations in the
MA and CA portions of the viral Gag gene (Crawford
and Goff, 1984; Hsu et al., 1985; Yu et al., 1992; Craven
et al., 1995; Alin and Goff, 1996; Casella et al., 1997;
Kiernan et al., 1998), mutations that block processing
of the Gag precursor to the mature forms (Crawford
and Goff, 1985; Katoh et al., 1985), and mutations af-
fecting the polymerase activity of reverse transcriptase
(RT) itself (Schwartzberg et al., 1984) are all arrested at
this stage. In the case of HIV-1, mutations that block
the interaction of Gag with cyclophilin A similarly
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block infection at this time (Braaten et al., 1996). The
corresponding behavior of the R4-7 line suggests that
some host protein that interacts with Gag or RT may
be required for normal DNA synthesis. A plausible
function for such a protein would be the opening of
the intracellular virion core to allow triphosphates to
enter and for reverse transcription to begin, or the
direct activation of RT. This protein would have to
interact with both MuLV and HIV-1 proteins, because
both are blocked at a similar stage, before DNA syn-
thesis. There seemed to be no additional blocks after
MuLV DNA synthesis, because the reduced amount of
linear viral DNA formed in the infected cells gave rise
to correspondingly and only the appropriately re-
duced levels of circular DNA forms.
The R3-2 cell line allowed normal reverse transcrip-
tion of both MuLV and HIV-1 DNAs, and infection
was blocked at later stages. The resulting preintegra-
tive MuLV DNA showed very aberrant properties.
Whereas a substantial fraction of the DNA in wild-
type cells was extracted in soluble form without de-
tergent, the bulk of the DNA in R3-2 cells was trapped
in insoluble fractions. This DNA was readily extracted
with nonionic or ionic detergents. Furthermore, there
was no formation of the two-LTR circular DNA, a
hallmark of entry into the nucleus, and no DNA could
be extracted from an initial crude nuclear fraction.
These results suggest that the trapped viral DNA was
unable to properly move into the nucleus in the mu-
tant cell line. It is possible that the DNA is bound to
cytoskeletal components in an inappropriately tight
association. There is considerable evidence that the
incoming virus complex may be carried into the cell
by cytoskeleton-associated transport mechanisms
(Kizhatil and Albritton, 1997), and this process may be
abnormal in the mutant line. The fact that there was a
quantitatively different effect on MuLV and HIV-1 is
consistent with the possibility that the Gag or Pol
proteins of the incoming virion might be the target.
The effect of the mutation in the R3-2 cells is remi-
niscent of the effects of another host gene, the Fv1
locus, which causes a dominant resistance to virus
infection (for reviews, see Jolicoeur, 1979; Goff, 1996).
Cells expressing the Fv1b allele are resistant to N-
tropic viruses, and those expressing the Fv1n allele are
resistant to B-tropic viruses. The determinants of viral
tropism lie in the CA region of the Gag gene (DesGro-
seillers and Jolicoeur, 1983; Ou et al., 1983). Interest-
ingly, the course of infection is blocked by Fv1 soon
after viral DNA synthesis, and before DNA integra-
tion (Jolicoeur and Baltimore, 1976); furthermore, the
preintegrative DNA is not extracted efficiently from
nonpermissive cells using standard buffer conditions
(Pryciak and Varmus, 1992). Thus, the R3-2 resistance
function seems to trap the viral DNA in a stage of
infection and in a state very similar to those of Fv1
resistance. There is no other evidence, however, to
suggest that the R3-2 block is directly related to Fv1.
Recently the Fv1 locus has been cloned and shown to
encode either of two variants of an endogenous retro-
viral Gag protein (Best et al., 1996); the mechanism of
its action, however, remains unclear.
Preliminary efforts to determine whether the resis-
tance mutations in R4-7 and R3-2 are genetically dom-
inant or recessive to the wild-type alleles by analysis
of somatic cell hybrids have been inconclusive. The
mutant cells were fused with normal human cells, and
the heterokaryons were challenged by infection with
ecotropic viral vectors. The mutant rat cells were re-
sistant by virtue of their intracellular block, and the
human cells were resistant because they lack the eco-
tropic virus receptor; if the mutations in the rat cells
were recessive, the heterokaryons would be virus sen-
sitive. Control experiments, however, suggested that
the fused cells were not reliably healthy enough to
always support good infection, and other approaches
will be required to address this issue more defini-
tively. Recent efforts to relieve the blocks by transfor-
mation with cDNA constructs have resulted in the
recovery of specific antisense cDNAs that restore virus
sensitivity. These results suggest that the lines may
contain a dominant-acting resistance gene, although
other models can explain these observations. The fur-
ther analysis of the block in these cells, and the iden-
tification of the genes responsible, should provide im-
portant information about the course of virus
infection.
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